Evogene Ltd. Anteile 2011-2026 | EVGN

Anteile Jährlich Evogene Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	40.4 M	28.2 M	25.8 M	25.8 M	25.7 M	25.4 M	25.4 M	25.1 M	19.5 M	18.4 M	17.5 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
40.4 M	17.5 M	25.2 M

Anteile anderer Aktien in der Pharmaeinzelhändler

Name	Anteile	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	16.8 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	19.2 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	17.9 M	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	187 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	54.8 M	$ 219.68	1.92 %	$ 5 B	Danmark
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Seres Therapeutics MCRB	128 M	$ 8.28	-	$ 1.06 B	USA
Amphastar Pharmaceuticals AMPH	46.7 M	$ 19.45	1.14 %	$ 909 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	1.08 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Mesoblast Limited MESO	649 M	$ 15.44	7.82 %	$ 10 B	Australia
Atreca BCEL	38.6 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	12.1 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	110 M	-	-	$ 546 M	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Cara Therapeutics CARA	54.1 M	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	15.8 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	11.5 M	$ 0.67	-5.25 %	$ 7.67 M	Israel
Mirum Pharmaceuticals MIRM	50.2 M	$ 90.39	2.86 %	$ 4.54 B	USA
Avenue Therapeutics ATXI	1.3 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	255 M	$ 1.34	1.52 %	$ 342 M	Britain
MediciNova MNOV	49.1 M	$ 1.45	-	$ 71.1 M	USA
CytomX Therapeutics CTMX	138 M	$ 4.37	2.95 %	$ 603 M	USA
Cyclacel Pharmaceuticals CYCC	22.3 M	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	69.9 K	-	-	$ 3.74 B	USA
Aytu BioScience AYTU	6.28 M	$ 2.69	1.37 %	$ 16.9 M	USA
Dynavax Technologies Corporation DVAX	130 M	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	99.3 M	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	165 M	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Merck & Co. MRK	2.5 B	$ 117.56	1.02 %	$ 294 B	USA
Marker Therapeutics MRKR	15.3 M	$ 1.37	8.73 %	$ 21 M	USA
Moderna MRNA	389 M	$ 53.09	3.41 %	$ 20.7 B	USA
Bellerophon Therapeutics BLPH	9.55 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	192 M	$ 4.47	3.71 %	$ 856 M	Canada
Homology Medicines FIXX	12.3 M	-	0.77 %	$ 53.4 M	USA